DMT is N,N-dimethyltryptamine, a compound causing brief and intense psychedelic experiences. Scientists are beginning to ...

Neither of the two plants have an hallucinogenic effect when taken individually. Yet when cooked together, the beta-carbolines found in the ayahuasca vine potentiate the dimethyl tryptamine (DMT ...

Tryptamine's TRP-8803 advances to Phase 2 trials, offering faster onset and safer control over psychedelic treatments via IV infusion. Phase 1b results highlight TRP-8803's precise dosing, safety ...

Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter Tryptamine Therapeutics has successfully completed its Phase 1b trial of TRP-8803, an IV-infused psilocin ...

Tryptamine Therapeutics (AU:TYP) has released an update. Tryptamine Therapeutics, a biotech company listed on ASX, announced the results of its 2024 Annual General Meeting, where all resolutions ...

Tryptamine receives firm commitments to raise $6m in placement strongly supported by new and existing stakeholders Placement cornerstoned by Merchant Biotech Fund and biotech investor Dr Daniel ...